Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
18
MRCHF Quote, Financials, Valuation and Earnings
Last price:
$21.00
Seasonality move
:
1.61%
Day range:
$21.00 - $21.00
52-week range:
$14.87 - $28.06
Dividend yield:
3.99%
P/E ratio:
48.25x
P/S ratio:
0.72x
P/B ratio:
1.31x
Volume:
50
Avg. volume:
148
1-year change:
31.5%
Market cap:
$1.2B
Revenue:
$1.6B
EPS (TTM):
$0.44
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MRCHF
H.U. Group Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
HLOSF
Healios KK
|
-- | -- | -- | -- | -- |
|
PPTDF
PeptiDream Inc.
|
-- | -- | -- | -- | -- |
|
SOLTF
Nxera Pharma Co., Ltd.
|
-- | -- | -- | -- | -- |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$7.8B | -- | 3.82% | -- | $17.93 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MRCHF
H.U. Group Holdings, Inc.
|
$21.00 | -- | $1.2B | 48.25x | $0.41 | 3.99% | 0.72x |
|
HLOSF
Healios KK
|
$1.93 | -- | $222.8M | -- | $0.00 | 0% | 303.04x |
|
PPTDF
PeptiDream Inc.
|
$11.98 | -- | $1.5B | 13.79x | $0.00 | 0% | 12.90x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$5.08 | -- | $459.3M | -- | $0.00 | 0% | 2.37x |
|
STMM
Stemcell Holdings, Inc.
|
$0.06 | -- | $60M | -- | $0.00 | 0% | 0.17x |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$15.58 | $17.93 | $49.2B | 197.72x | $0.32 | 4.24% | 1.68x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MRCHF
H.U. Group Holdings, Inc.
|
34.24% | 0.861 | 35.33% | 1.31x |
|
HLOSF
Healios KK
|
47.23% | -1.205 | 3.71% | 1.23x |
|
PPTDF
PeptiDream Inc.
|
25.86% | 0.045 | 8.66% | 4.05x |
|
SOLTF
Nxera Pharma Co., Ltd.
|
49.02% | 1.721 | 73.82% | 2.21x |
|
STMM
Stemcell Holdings, Inc.
|
-- | 0.000 | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
39.45% | -0.563 | 68.02% | 0.64x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MRCHF
H.U. Group Holdings, Inc.
|
$121.8M | $9.9M | 1.69% | 2.63% | 2.31% | $30.2M |
|
HLOSF
Healios KK
|
-$637.4K | -$5.2M | -86.08% | -194.37% | -4022.21% | -$5.3M |
|
PPTDF
PeptiDream Inc.
|
$11.3M | -$9.7M | -7.71% | -10.42% | -33.1% | -$12.5M |
|
SOLTF
Nxera Pharma Co., Ltd.
|
$27.7M | -$23.7M | -4.62% | -9.2% | -51.66% | -$20.9M |
|
STMM
Stemcell Holdings, Inc.
|
-- | -- | -- | -- | -- | -- |
|
TAK
Takeda Pharmaceutical Co., Ltd.
|
$3.6B | $763.2M | 0.33% | 0.55% | 10.11% | $2B |
H.U. Group Holdings, Inc. vs. Competitors
-
Which has Higher Returns MRCHF or HLOSF?
Healios KK has a net margin of 2.18% compared to H.U. Group Holdings, Inc.'s net margin of -9751.87%. H.U. Group Holdings, Inc.'s return on equity of 2.63% beat Healios KK's return on equity of -194.37%.
Company Gross Margin Earnings Per Share Invested Capital MRCHFH.U. Group Holdings, Inc.28.52% $0.17 $1.4B HLOSFHealios KK-494.88% $0.03 $37.8M -
What do Analysts Say About MRCHF or HLOSF?
H.U. Group Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Healios KK has an analysts' consensus of -- which suggests that it could fall by --. Given that H.U. Group Holdings, Inc. has higher upside potential than Healios KK, analysts believe H.U. Group Holdings, Inc. is more attractive than Healios KK.
Company Buy Ratings Hold Ratings Sell Ratings MRCHFH.U. Group Holdings, Inc.0 0 0 HLOSFHealios KK0 0 0 -
Is MRCHF or HLOSF More Risky?
H.U. Group Holdings, Inc. has a beta of 0.534, which suggesting that the stock is 46.585% less volatile than S&P 500. In comparison Healios KK has a beta of 0.210, suggesting its less volatile than the S&P 500 by 78.954%.
-
Which is a Better Dividend Stock MRCHF or HLOSF?
H.U. Group Holdings, Inc. has a quarterly dividend of $0.41 per share corresponding to a yield of 3.99%. Healios KK offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. H.U. Group Holdings, Inc. pays 257.2% of its earnings as a dividend. Healios KK pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MRCHF or HLOSF?
H.U. Group Holdings, Inc. quarterly revenues are $427.2M, which are larger than Healios KK quarterly revenues of $128.8K. H.U. Group Holdings, Inc.'s net income of $9.3M is higher than Healios KK's net income of $3.8M. Notably, H.U. Group Holdings, Inc.'s price-to-earnings ratio is 48.25x while Healios KK's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for H.U. Group Holdings, Inc. is 0.72x versus 303.04x for Healios KK. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRCHFH.U. Group Holdings, Inc.0.72x 48.25x $427.2M $9.3M HLOSFHealios KK303.04x -- $128.8K $3.8M
-
Which has Higher Returns MRCHF or PPTDF?
PeptiDream Inc. has a net margin of 2.18% compared to H.U. Group Holdings, Inc.'s net margin of -25.38%. H.U. Group Holdings, Inc.'s return on equity of 2.63% beat PeptiDream Inc.'s return on equity of -10.42%.
Company Gross Margin Earnings Per Share Invested Capital MRCHFH.U. Group Holdings, Inc.28.52% $0.17 $1.4B PPTDFPeptiDream Inc.38.71% -$0.06 $480.4M -
What do Analysts Say About MRCHF or PPTDF?
H.U. Group Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand PeptiDream Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that H.U. Group Holdings, Inc. has higher upside potential than PeptiDream Inc., analysts believe H.U. Group Holdings, Inc. is more attractive than PeptiDream Inc..
Company Buy Ratings Hold Ratings Sell Ratings MRCHFH.U. Group Holdings, Inc.0 0 0 PPTDFPeptiDream Inc.0 0 0 -
Is MRCHF or PPTDF More Risky?
H.U. Group Holdings, Inc. has a beta of 0.534, which suggesting that the stock is 46.585% less volatile than S&P 500. In comparison PeptiDream Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.146%.
-
Which is a Better Dividend Stock MRCHF or PPTDF?
H.U. Group Holdings, Inc. has a quarterly dividend of $0.41 per share corresponding to a yield of 3.99%. PeptiDream Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. H.U. Group Holdings, Inc. pays 257.2% of its earnings as a dividend. PeptiDream Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MRCHF or PPTDF?
H.U. Group Holdings, Inc. quarterly revenues are $427.2M, which are larger than PeptiDream Inc. quarterly revenues of $29.3M. H.U. Group Holdings, Inc.'s net income of $9.3M is higher than PeptiDream Inc.'s net income of -$7.4M. Notably, H.U. Group Holdings, Inc.'s price-to-earnings ratio is 48.25x while PeptiDream Inc.'s PE ratio is 13.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for H.U. Group Holdings, Inc. is 0.72x versus 12.90x for PeptiDream Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRCHFH.U. Group Holdings, Inc.0.72x 48.25x $427.2M $9.3M PPTDFPeptiDream Inc.12.90x 13.79x $29.3M -$7.4M
-
Which has Higher Returns MRCHF or SOLTF?
Nxera Pharma Co., Ltd. has a net margin of 2.18% compared to H.U. Group Holdings, Inc.'s net margin of -24.76%. H.U. Group Holdings, Inc.'s return on equity of 2.63% beat Nxera Pharma Co., Ltd.'s return on equity of -9.2%.
Company Gross Margin Earnings Per Share Invested Capital MRCHFH.U. Group Holdings, Inc.28.52% $0.17 $1.4B SOLTFNxera Pharma Co., Ltd.60.42% -$0.13 $872.1M -
What do Analysts Say About MRCHF or SOLTF?
H.U. Group Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Nxera Pharma Co., Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that H.U. Group Holdings, Inc. has higher upside potential than Nxera Pharma Co., Ltd., analysts believe H.U. Group Holdings, Inc. is more attractive than Nxera Pharma Co., Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MRCHFH.U. Group Holdings, Inc.0 0 0 SOLTFNxera Pharma Co., Ltd.0 0 0 -
Is MRCHF or SOLTF More Risky?
H.U. Group Holdings, Inc. has a beta of 0.534, which suggesting that the stock is 46.585% less volatile than S&P 500. In comparison Nxera Pharma Co., Ltd. has a beta of 0.029, suggesting its less volatile than the S&P 500 by 97.149%.
-
Which is a Better Dividend Stock MRCHF or SOLTF?
H.U. Group Holdings, Inc. has a quarterly dividend of $0.41 per share corresponding to a yield of 3.99%. Nxera Pharma Co., Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. H.U. Group Holdings, Inc. pays 257.2% of its earnings as a dividend. Nxera Pharma Co., Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MRCHF or SOLTF?
H.U. Group Holdings, Inc. quarterly revenues are $427.2M, which are larger than Nxera Pharma Co., Ltd. quarterly revenues of $45.8M. H.U. Group Holdings, Inc.'s net income of $9.3M is higher than Nxera Pharma Co., Ltd.'s net income of -$11.3M. Notably, H.U. Group Holdings, Inc.'s price-to-earnings ratio is 48.25x while Nxera Pharma Co., Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for H.U. Group Holdings, Inc. is 0.72x versus 2.37x for Nxera Pharma Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRCHFH.U. Group Holdings, Inc.0.72x 48.25x $427.2M $9.3M SOLTFNxera Pharma Co., Ltd.2.37x -- $45.8M -$11.3M
-
Which has Higher Returns MRCHF or STMM?
Stemcell Holdings, Inc. has a net margin of 2.18% compared to H.U. Group Holdings, Inc.'s net margin of --. H.U. Group Holdings, Inc.'s return on equity of 2.63% beat Stemcell Holdings, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MRCHFH.U. Group Holdings, Inc.28.52% $0.17 $1.4B STMMStemcell Holdings, Inc.-- -- -- -
What do Analysts Say About MRCHF or STMM?
H.U. Group Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Stemcell Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that H.U. Group Holdings, Inc. has higher upside potential than Stemcell Holdings, Inc., analysts believe H.U. Group Holdings, Inc. is more attractive than Stemcell Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MRCHFH.U. Group Holdings, Inc.0 0 0 STMMStemcell Holdings, Inc.0 0 0 -
Is MRCHF or STMM More Risky?
H.U. Group Holdings, Inc. has a beta of 0.534, which suggesting that the stock is 46.585% less volatile than S&P 500. In comparison Stemcell Holdings, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MRCHF or STMM?
H.U. Group Holdings, Inc. has a quarterly dividend of $0.41 per share corresponding to a yield of 3.99%. Stemcell Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. H.U. Group Holdings, Inc. pays 257.2% of its earnings as a dividend. Stemcell Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MRCHF or STMM?
H.U. Group Holdings, Inc. quarterly revenues are $427.2M, which are larger than Stemcell Holdings, Inc. quarterly revenues of --. H.U. Group Holdings, Inc.'s net income of $9.3M is higher than Stemcell Holdings, Inc.'s net income of --. Notably, H.U. Group Holdings, Inc.'s price-to-earnings ratio is 48.25x while Stemcell Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for H.U. Group Holdings, Inc. is 0.72x versus 0.17x for Stemcell Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRCHFH.U. Group Holdings, Inc.0.72x 48.25x $427.2M $9.3M STMMStemcell Holdings, Inc.0.17x -- -- --
-
Which has Higher Returns MRCHF or TAK?
Takeda Pharmaceutical Co., Ltd. has a net margin of 2.18% compared to H.U. Group Holdings, Inc.'s net margin of -1.05%. H.U. Group Holdings, Inc.'s return on equity of 2.63% beat Takeda Pharmaceutical Co., Ltd.'s return on equity of 0.55%.
Company Gross Margin Earnings Per Share Invested Capital MRCHFH.U. Group Holdings, Inc.28.52% $0.17 $1.4B TAKTakeda Pharmaceutical Co., Ltd.47.41% -$0.03 $79.7B -
What do Analysts Say About MRCHF or TAK?
H.U. Group Holdings, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Takeda Pharmaceutical Co., Ltd. has an analysts' consensus of $17.93 which suggests that it could grow by 14.94%. Given that Takeda Pharmaceutical Co., Ltd. has higher upside potential than H.U. Group Holdings, Inc., analysts believe Takeda Pharmaceutical Co., Ltd. is more attractive than H.U. Group Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MRCHFH.U. Group Holdings, Inc.0 0 0 TAKTakeda Pharmaceutical Co., Ltd.3 0 0 -
Is MRCHF or TAK More Risky?
H.U. Group Holdings, Inc. has a beta of 0.534, which suggesting that the stock is 46.585% less volatile than S&P 500. In comparison Takeda Pharmaceutical Co., Ltd. has a beta of 0.032, suggesting its less volatile than the S&P 500 by 96.811%.
-
Which is a Better Dividend Stock MRCHF or TAK?
H.U. Group Holdings, Inc. has a quarterly dividend of $0.41 per share corresponding to a yield of 3.99%. Takeda Pharmaceutical Co., Ltd. offers a yield of 4.24% to investors and pays a quarterly dividend of $0.32 per share. H.U. Group Holdings, Inc. pays 257.2% of its earnings as a dividend. Takeda Pharmaceutical Co., Ltd. pays out 242.25% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MRCHF or TAK?
H.U. Group Holdings, Inc. quarterly revenues are $427.2M, which are smaller than Takeda Pharmaceutical Co., Ltd. quarterly revenues of $7.5B. H.U. Group Holdings, Inc.'s net income of $9.3M is higher than Takeda Pharmaceutical Co., Ltd.'s net income of -$79.5M. Notably, H.U. Group Holdings, Inc.'s price-to-earnings ratio is 48.25x while Takeda Pharmaceutical Co., Ltd.'s PE ratio is 197.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for H.U. Group Holdings, Inc. is 0.72x versus 1.68x for Takeda Pharmaceutical Co., Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MRCHFH.U. Group Holdings, Inc.0.72x 48.25x $427.2M $9.3M TAKTakeda Pharmaceutical Co., Ltd.1.68x 197.72x $7.5B -$79.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 1.3% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 6.78% over the past day.
